Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Norvasc Generic Substitution Rate Reaches Nearly 77 Percent

Apr 24 2007

• By Jonathan M. Block

Related Content

Mylan, Pfizer On The Same Side Over FDA Approval Of Pending Norvasc ANDAs

Apr 09 2007

Mylan Launches Generic Norvasc; 180-Day Exclusivity May Be Moot

Mar 23 2007

Generic Norvasc May Launch Sooner Than Expected Following Appellate Court Ruling

Mar 22 2007

Additional Topics

BioPharmaceutical

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window